Fig. 4From: Key regulators of sensitivity to immunomodulatory drugs in cancer treatmentGeneral regulators required for IMiD sensitivity and frequently mutant genes or dysregulated pathways in IMiD-resistant cells. These findings are summarized mainly from studies in MM, or other conditions specifiedBack to article page